My take on CXR part 3Among 60 drugs to be launched by the end of 2018, if 2 or 3 drugs become popular with 50 m to 100 m annual sale, that will change everything, SP will be back to $100. Of course this is scenario for investors not for traders.
For traders, the takeover is the best bet. Some anaylist put 7.5 to 8 time ratio to have CXR evaluated to be $22, The takeover price is difficult to be over $25. My assmption is between $20 to $25. CXR may announce this privatization news when shorts least expect it. They are going to lose 3 time money they invested.
Whether you are trader or investor, CXR is a good bet at present.